News
SSKN
3.340
+1.21%
0.040
Strata Skin Sciences Completes $2.1M Direct Share Offering
TipRanks · 3d ago
STRATA SKIN SCIENCES COMPLETES $2.1 MILLION DIRECT OFFERING WITH PARTICIPATION FROM INSIDERS
Reuters · 3d ago
STRATA Skin Sciences gets approval for its excimer laser device in Japan
Seeking Alpha · 4d ago
STRATA SKIN SCIENCES ANNOUNCES APPROVAL OF XTRAC MOMENTUM™ 1.0 DEVICE IN JAPAN
Reuters · 4d ago
Weekly Report: what happened at SSKN last week (0715-0719)?
Weekly Report · 4d ago
Strata Skin Sciences’ TheraClear®X Acne Therapy Breakthrough
TipRanks · 07/17 12:29
STRATA Skin Sciences' TheraClearX Acne Therapy System Found Safe And Effective In Study Published In The July 11, 2024 Issue Of The Journal Of Cosmetic And Laser Therapy
Study published in Journal of Cosmetic and Laser Therapy highlights the TheraClear®X photopneumatic device as an effective treatment option for patients with mild-moderate acne. The study was published in the July 11, 2024 issue of the Journal of cosmetic and laser therapy. The Theraclear®X Acne Therapy System was shown to reduce lesions and reduce redness.
Benzinga · 07/17 12:10
Weekly Report: what happened at SSKN last week (0708-0712)?
Weekly Report · 07/15 11:50
STRATA Skin Sciences reports Q2 results
Healthcare STRATA Skin Sciences reports Q2 results. The company added that the domestic installed base of XTRAC devices declined from 907 at the end of Q1 to 881 in Q2. Preliminary total revenue for the second quarter in the range of $8.4M.
Seeking Alpha · 07/11 13:46
Strata Skin Sciences Reports Mixed Q2 Financials and Device Installations
TipRanks · 07/11 12:28
STRATA Skin Sciences Preliminary Q2 2024 Revenue Guidance Of $8M-$8.4M Vs $7.42M Est.
STRATA Skin Sciences, Inc. Announces preliminary total revenue for the second quarter of 2024 in the range of $8.0 million. The Company is a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions. The domestic installed base of XTRAC devices declined.
Benzinga · 07/11 12:04
*Strata Skin Sciences Sees 2Q Rev $8.0M-$8.4M >SSKN
Dow Jones · 07/11 12:01
STRATA SKIN SCIENCES PRE-ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS
Reuters · 07/11 12:00
STRATA SKIN SCIENCES INC - ANNOUNCES PRELIMINARY TOTAL REV IN RANGE OF $8.0 MLN - $8.4 MLN FOR Q2 OF 2024
Reuters · 07/11 12:00
Press Release: STRATA Skin Sciences Pre-Announces Second Quarter 2024 Financial Results
Dow Jones · 07/11 12:00
Weekly Report: what happened at SSKN last week (0701-0705)?
Weekly Report · 07/08 11:52
Weekly Report: what happened at SSKN last week (0624-0628)?
Weekly Report · 07/01 11:53
Weekly Report: what happened at SSKN last week (0617-0621)?
Weekly Report · 06/24 12:02
Weekly Report: what happened at SSKN last week (0610-0614)?
Weekly Report · 06/17 11:51
SSKN Stock Earnings: Strata Skin Sciences Misses EPS, Misses Revenue for Q2 2023
Strata Skin Sciences reported results for the second quarter of 2023. The company reported earnings per share of -90 cents and revenue of $8.25 million. This was below the analyst estimate of -50 cents for the same period. Strata skin Sciences is a maker of skin care products.
Investorplace · 06/10 15:53
More
Webull provides a variety of real-time SSKN stock news. You can receive the latest news about Strata Skin Sciences Inc through multiple platforms. This information may help you make smarter investment decisions.
About SSKN
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.